Type 2 diabetes mellitus is a chronic, progressive condition characterized by insulin resistance and impaired insulin secretion, leading to persistent hyperglycaemia. Effective glycaemic control is essential to prevent or delay diabetes-related complications such as neuropathy, nephropathy, retinopathy, and cardiovascular disease.

Linatab D 5/10 combines two agents with complementary mechanisms of action:

• Linagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, increases the levels of incretin hormones (GLP-1 and GIP), which enhance insulin secretion and suppress glucagon release in a glucose-dependent manner.
• Dapagliflozin, a Sodium-Glucose Cotransporter-2 (SGLT2) inhibitor, reduces blood glucose by promoting urinary glucose excretion through inhibition of renal glucose reabsorption.

Together, these agents improve glycaemic control through both insulin-dependent and insulin-independent pathways, providing better fasting and postprandial blood glucose management with additional benefits such as weight reduction and blood pressure improvement.

USES:

• Management of Type 2 Diabetes Mellitus in adults
• As an adjunct to diet and exercise for improved glycaemic control
• May be used as combination therapy when monotherapy with either component is insufficient

MEDICINAL BENEFITS:

• Dual mechanism for optimal glycaemic control
• Promotes mild weight loss and blood pressure reduction
• Low risk of hypoglycaemia when used as directed
• Provides cardiovascular and renal protection benefits associated with Dapagliflozin
• Improves beta-cell function and insulin sensitivity

DOSAGE & ADMINISTRATION:
Dosage should be individualized based on patient needs and clinical response. The usual recommended dose is one tablet once daily, taken with or without food. Swallow the tablet whole with a glass of water. Do not crush or chew. Continue therapy as directed by your physician.

STORAGE:
Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.

CONTRAINDICATIONS:

• Hypersensitivity to Linagliptin, Dapagliflozin, or any excipients
• Severe renal impairment (eGFR < 30 mL/min/1.73 m²) or patients on dialysis
• Type 1 diabetes mellitus or diabetic ketoacidosis
• History of serious hypersensitivity reactions (e.g., angioedema) to DPP-4 inhibitors

WARNINGS & PRECAUTIONS:

• Use with cautions
• Maintain adequate hydration to prevent dehydration and hypotension
• Monitor for signs of urinary tract infections or genital mycotic infections
• Temporarily discontinue before surgery or during acute illness to avoid ketoacidosis risk
• Avoid excessive alcohol intake during therapy
• Use in pregnancy or lactation only under medical supervision

SIDE EFFECTS:
Common side effects may include increased urination, mild urinary tract infection, genital fungal infection, headache, nasopharyngitis, or mild hypoglycaemia (especially if used with other antidiabetic agents). Most effects are transient and mild. Consult your doctor if any side effects persist or worsen.

DISCLAIMER:
Linatab D 5/10 should be used only under the supervision of a qualified healthcare professional. Dosage and duration must be based on medical advice, patient response, and blood glucose monitoring.

The post LINATAB D 5/10 (Linagliptin 5 mg + Dapagliflozin 10 mg Tablets) appeared first on Jovaras.

Type 2 diabetes mellitus is a chronic metabolic disorder characterized by insulin resistance and insufficient insulin secretion, leading to elevated blood glucose levels. Proper glycaemic control helps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular diseases.

Linatab MOD 5/500 SR combines two complementary agents that work synergistically:

• Linagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, increases the levels of incretin hormones, which enhance insulin secretion and suppress glucagon release after meals, helping maintain glucose control.
• Metformin SR, a biguanide, reduces hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity in peripheral tissues. Its sustained-release formulation ensures a gradual and prolonged therapeutic effect with improved gastrointestinal tolerance.

Together, these components effectively reduce both fasting and postprandial blood glucose levels, providing stable and long-term glycaemic control.

USES:

• Management of Type 2 Diabetes Mellitus in adults
• As an adjunct to diet and exercise to improve blood glucose control
• May be used as dual therapy when monotherapy with metformin or linagliptin alone is insufficient

MEDICINAL BENEFITS:

• Provides a dual mechanism of action for effective glycaemic control
• Low risk of hypoglycaemia when used as directed
• Improves insulin sensitivity and enhances endogenous insulin release
• Sustained-release formulation offers better gastrointestinal tolerance and once-daily convenience
• May support weight stability or modest reduction

DOSAGE & ADMINISTRATION:
Dosage should be individualized based on patient response and tolerance. The usual recommended dose is one tablet once daily, taken with meals to minimize gastrointestinal discomfort. Swallow the tablet whole with water. Do not crush or chew. Continue therapy as advised by the physician.

STORAGE:
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of reach of children.

CONTRAINDICATIONS:

• Known hypersensitivity to Linagliptin, Metformin, or any component of the formulation
• Severe renal impairment or end-stage renal disease (eGFR < 30 mL/min/1.73 m²)
• Acute or chronic metabolic acidosis, including diabetic ketoacidosis
• Conditions associated with hypoxia (e.g., heart failure, respiratory failure, myocardial infarction)

WARNINGS & PRECAUTIONS:

• Use with caution in patients with renal or hepatic impairment
• Avoid excessive alcohol consumption to reduce the risk of lactic acidosis
• Temporarily discontinue before major surgery or radiologic procedures involving iodinated contrast
• Monitor renal function and blood glucose regularly during therapy
• Use during pregnancy or lactation only under medical supervision

SIDE EFFECTS:
Common side effects may include mild gastrointestinal discomfort such as nausea, diarrhoea, or abdominal pain, especially during initial therapy. Rarely, hypoglycaemia, headache, or upper respiratory tract infection may occur. Most effects are mild and resolve with continued use.

DISCLAIMER:
Linatab MOD 5/500 SR should be used strictly under medical supervision. Dosage and duration should be based on individual clinical assessment and blood glucose monitoring.

The post LINATAB MOD 5/500 SR (Linagliptin 5 mg + Metformin Hydrochloride 500 mg SR Tablets) appeared first on Jovaras.

Type 2 diabetes mellitus is a chronic metabolic disorder in which the body either does not produce enough insulin or cannot effectively utilize it (insulin resistance). Uncontrolled blood sugar levels over time can lead to serious complications such as neuropathy, nephropathy, retinopathy, and cardiovascular diseases.

Linatab E 5/25 combines two complementary mechanisms of action. Linagliptin is a Dipeptidyl Peptidase-4 (DPP-4) inhibitor that works by increasing incretin hormone levels, which help regulate blood glucose by stimulating insulin secretion and suppressing glucagon release after meals. Empagliflozin is a Sodium-Glucose Cotransporter-2 (SGLT2) inhibitor that lowers blood glucose levels by promoting glucose excretion through urine. It also offers additional cardiovascular and renal benefits in patients with type 2 diabetes. Together, these agents effectively reduce both fasting and postprandial blood glucose levels, improve glycaemic control, and support weight and blood pressure reduction.

USES:
For the treatment of Type 2 Diabetes Mellitus in adults. As an adjunct to diet and exercise to improve glycaemic control. May be used as dual therapy or in combination with other antidiabetic agents (e.g., metformin or insulin) as prescribed by a healthcare professional.

MEDICINAL BENEFITS:
Provides a dual mechanism of glucose reduction through both insulin-dependent and insulin-independent pathways. Helps maintain better overall glycaemic control throughout the day. May promote weight reduction and lower systolic blood pressure. Has a low risk of hypoglycaemia when used as monotherapy or with metformin. Demonstrated cardiovascular and renal protection benefits with empagliflozin.

DOSAGE & ADMINISTRATION:
Dosage should be individualized based on the patient’s condition and response. The usual recommended dose is one tablet once daily, taken in the morning with or without food. Swallow the tablet whole with a glass of water. Do not crush or chew. Continue therapy as directed by your physician and do not discontinue without medical advice.

STORAGE:
Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children.

WARNINGS & PRECAUTIONS:
Use cautiously. Maintain adequate hydration to prevent dehydration due to increased urination. Monitor for symptoms of urinary tract or genital mycotic infections. Temporarily discontinue before major surgery or in cases of acute illness with reduced food or fluid intake. Avoid alcohol consumption. Use during pregnancy and breastfeeding only if clearly needed and under medical supervision.

SIDE EFFECTS:
Common side effects may include increased urination, urinary tract infection, genital fungal infection, thirst, dehydration, mild hypotension, nasopharyngitis, upper respiratory tract infection, headache, or joint pain. Most effects are mild and resolve on their own. Consult your doctor if any symptoms persist or become bothersome.

DISCLAIMER:
Linatab E 5/25 should be taken strictly under medical supervision. Dosage and duration must be individualized based on blood glucose response and clinical judgement.

The post LINATAB E 5/25 (Linagliptin 5 mg + Empagliflozin 25 mg Tablets) appeared first on Jovaras.

Glimitate M1 is a combination of two antidiabetic drugs, namely: Glimepiride and Metformin. Glimepiride works by stimulating beta cells in the pancreas that produce insulin. Thus, insulin helps to remove sugar from the blood. Metformin SR is a Sustained-release formulation that releases the drug in smaller portions over a longer duration of time. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood.

Take Glimitate M1 as prescribed by your doctor. You are advised to take GLIMEPIRIDE+METFORMIN for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience stomach pain, nausea, diarrhoea, vomiting, headache or metallic taste. Most of these side effects of GLIMEPIRIDE+METFORMIN do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to GLIMEPIRIDE+METFORMIN or any other medicines, please tell your doctor. GLIMEPIRIDE+METFORMIN is not recommended for children. Avoid breastfeeding while taking GLIMEPIRIDE+METFORMIN as it may be excreted in human milk.

If you are pregnant or planning for pregnancy, please inform your doctor before taking GLIMEPIRIDE+METFORMIN as it may harm the unborn baby. Avoid alcohol consumption with GLIMEPIRIDE+METFORMIN as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body). Drive only if you are alert after taking GLIMEPIRIDE+METFORMIN. Take short, frequent meals and avoid prolonged fasting while taking GLIMEPIRIDE+METFORMIN.

Uses of Glimitate M1
In Type 2 diabetes mellitus
Medicinal Benefits
Glimitate M1 contains Glimepiride 1mg and Metformin 500mg used in the treatment of type 2 diabetes. Glimepiride stimulates cells in the pancreas that produce insulin which helps to remove sugar from the blood. Metformin PR is a prolonged-release formulation that releases the drug in smaller portions over a longer duration of time. Metformin reduces sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood.

DOSAGE & ADMINISTRATION:
General
Dosage should be individualized based on both effectiveness and tolerance. The combination should be given once daily (daily) with meals and should be started at a low dose. The initial recommended dose is one tablet once daily with breakfast or the first main meal of the day and gradually titrated after assessing the adequacy of the therapeutic response.
Directions for Use
Take GLIMEPIRIDE+METFORMIN as advised by your doctor. Swallow it as a whole with a glass of water. Do not crush or break it.
Storage
Store in a cool and dry place away from sunlight

CONTRAINDICATIONS:
1. Renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels 1.5 mg/dL [males], 1.4 mg/dL [females] or abnormal creatinine clearance), which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and Septicaemia.
2. Congestive heart failure requiring pharmacologic treatment.
3. Known hypersensitivity to this product or any of its components.
4. Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. Diabetic ketoacidosis should be treated with insulin.
5. Patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials, because the use of such products may result in acute alteration of renal function.

The post GLIMITATE M 1 appeared first on Jovaras.

Glimitate M2 is with a combination of two antidiabetic drugs, namely: Glimepiride and Metformin. Glimepiride works by stimulating beta cells in the pancreas that produce insulin. Thus, insulin helps to remove sugar from the blood. Metformin SR is a Sustained-release formulation that releases the drug in smaller portions over a longer duration of time. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood.

Take GLIMEPIRIDE+METFORMIN as prescribed by your doctor. You are advised to take GLIMEPIRIDE+METFORMIN for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience stomach pain, nausea, diarrhoea, vomiting, headache or metallic taste. Most of these side effects of GLIMEPIRIDE+METFORMIN do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to GLIMEPIRIDE+METFORMIN or any other medicines, please tell your doctor. GLIMEPIRIDE+METFORMIN is not recommended for children. Avoid breastfeeding while taking GLIMEPIRIDE+METFORMIN as it may be excreted in human milk. If you are pregnant or planning for pregnancy, please inform your doctor before taking GLIMEPIRIDE+METFORMIN as it may harm the unborn baby. Avoid alcohol consumption with GLIMEPIRIDE+METFORMIN as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body). Drive only if you are alert after taking GLIMEPIRIDE+METFORMIN. Take short, frequent meals and avoid prolonged fasting while taking GLIMEPIRIDE+METFORMIN.

Uses of Glimitate M2
In Type 2 diabetes mellitus
Medicinal Benefits
Glimitate M2 contains Glimepiride 2mg and Metformin 500mg used in the treatment of type 2 diabetes. Glimepiride stimulates cells in the pancreas that produce insulin which helps to remove sugar from the blood. Metformin PR is a prolonged-release formulation that releases the drug in smaller portions over a longer duration of time. Metformin reduces sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood.
DOSAGE & ADMINISTRATION:
General
Dosage should be individualized on the basis of both effectiveness and tolerance. The combination should be given once daily (daily) with meals and should be started at a low dose. The initial recommended dose is one tablet once daily with breakfast or the first main meal of the day and gradually titrated after assessing the adequacy of the therapeutic response.

Directions for Use
Take GLIMITATE M2 as advised by your doctor. Swallow it as a whole with a glass of water. Do not crush or break it.
Storage
Store in a cool and dry place away from sunlight

CONTRAINDICATIONS:
1. Renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels 1.5 mg/dL [males], 1.4 mg/dL [females] or abnormal creatinine clearance), which may also result from condition s such as cardiovascular collapse (shock), acute myocardial infarction, and septicaemia.
2. Congestive heart failure requiring pharmacologic treatment.
3. Known hypersensitivity to this product or any of its components.
4. Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. Diabetic ketoacidosis should be treated with insulin.
5. Patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials, because the use of such products may result in acute alteration of renal function.

The post GLIMITATE M 2 appeared first on Jovaras.

GLIMITATE TRIO is a combination of three medicines, namely: Metformin, Glimepiride, and Pioglitazone. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Glimepiride acts by increasing the amount of insulin released by the pancreas. Pioglitazone works by decreasing the amount of glucose released by the liver and also by improving the sensitivity of tissues towards insulin effects.

You should take this medicine as prescribed by your doctor. You may experience side-effects of such as nausea (feeling sick), vomiting (falling sick), diarrhea, headache, stomach ache, respiratory infection, weight gain, sweating, palpitations, and vision problems. Some patients experience decline in blood sugar levels lower than normal (hypoglycemia) resulting in sweating, dizziness, headache, confusion, feeling hungry, temporary changes in vision, uneasiness, irritability, and weakness. In such cases, seek medical attention immediately.

Do not take GLIMEPIRIDE+METFORMIN+PIOGLITAZONE if you are allergic to any of its contents. Do not use this medicine if you have heart failure, bladder cancer, or diabetic ketoacidosis (a complication of diabetes). GLIMEPIRIDE+METFORMIN+PIOGLITAZONE may cause ‘lactic acidosis’ (accumulation of lactic acid in the blood), which requires immediate medical attention. The risk increases if you are previously diagnosed with kidney or liver diseases. Do not consume alcohol (risk of lactic acidosis) or fast for prolonged periods (risk of hypoglycemia). Also, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Uses of GLIMITATE TRIO
In Type 2 Diabetes Mellitus
Medicinal Benefits
GLIMITATE TRIO contains Metformin, Glimepiride, and Pioglitazone. GLIMITATE TRIO is given when single or dual therapy of hypoglycemic agents is not effective in diabetes patients. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Glimepiride acts by increasing the secretion of insulin by the pancreas. Pioglitazone works by decreasing the amount of glucose released by the liver and improving insulin sensitivity in muscle and fat.
Directions for Use
Take GLIMITATE TRIO as advised by your doctor. Swallow it as a whole with a glass of water. Do not crush, chew, or break it.
Storage
Store in a cool and dry place away from sunlight

CONTRAINDICATIONS:
1. Renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels 1.5 mg/dL [males], 1.4 mg/dL [females] or abnormal creatinine clearance), which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and septicaemia.
2. Congestive heart failure requiring pharmacologic treatment.
3. Known hypersensitivity to this product or any of its components.
4. Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. Diabetic ketoacidosis should be treated with insulin.
5. Patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials, because the use of such products may result in acute alteration of renal function.

The post GLIMITATE TRIO 2 appeared first on Jovaras.

Benefit of B BLEND:
1. Energy Production: B vitamins (such as B1, B2, B3, B5, B6, B9, and B12) are essential for converting the food you eat into energy. They play a key role in metabolism.
2. Cell Growth and Division: B vitamins are involved in DNA synthesis and cell division, promoting the growth and development of cells.
3. Nervous System Support: Certain B vitamins, like B6, B9, and B12, are crucial for the proper functioning of the nervous system. They help in the production of neurotransmitters and support nerve health.
4. Red Blood Cell Formation: B vitamins, particularly B6, B9, and B12, are essential for the formation of red blood cells, which carry oxygen throughout the body.
5. Immune System Function: B vitamins contribute to a healthy immune system, supporting the body’s defense against infections and illnesses.
6. Skin and Hair Health: B vitamins play a role in maintaining healthy skin, hair, and nails.
7. Mood Regulation: Some B vitamins, like B6, are involved in the synthesis of neurotransmitters such as serotonin, contributing to mood regulation.
8. Cardiovascular Health: B vitamins, such as B6, B12, and folic acid (B9), are important for cardiovascular health and may help lower homocysteine levels, which is associated with heart disease.
9. Vitamin C (Ascorbic Acid): Vitamin C is an antioxidant that supports the immune system, helps the body absorb iron. Promotes collagen formation, important for the skin to promote skin health, blood vessels, and bones.
10. Vitamin A: Vitamin A is essential for vision, immune function, and skin health. Also Important for the health of the eyes and may prevent night blindness.
11. Manganese: Manganese is a trace mineral involved in bone formation, blood clotting, and reducing inflammation.
12. Chromium: Chromium is a mineral that plays a role in insulin function and glucose metabolism, potentially assisting in blood sugar control.
13. Selenium: Selenium is a trace element with antioxidant properties, supporting immune function and thyroid health.
14. Zinc: Zinc is a vital mineral involved in immune function, wound healing, and DNA synthesis.

Directions for Use:
Swallow the Tablet as a whole with a glass of water. Do not crush, chew, or break it.
INDICATION: As an adjuvant
• In Type 1 and Type 2 Diabetes Management to Prevent Complications
• To Diet and Exercise in IGT Patients
• In the Treatment of Diabetic Peripheral Neuropathy
• In High-Risk Group People who are Prone to Diabetes and Cardio-Vascular Disease
• To Address Nutritional Deficiencies
• To Enhance Immunity & To Prevent Frequent Infections

Storage:
Store in a cool and dry place away from sunlight.

Side Effects of B-Complex:
B-Complex supplements are generally considered safe when taken as directed, and side effects are rare. However, in some cases, individuals may experience mild side effects. These can include:
Upset Stomach: Some people may experience mild stomach upset or nausea. Taking the supplement with food can help alleviate this.
Allergic Reactions: In rare cases, individuals may be allergic to certain components of the B-Complex supplement, leading to allergic reactions. If you notice any signs of an allergic reaction (such as rash, itching, swelling, severe dizziness), seek medical attention promptly.

The post B BLEND appeared first on Jovaras.

Common Side Effects:
Common side effects may include headache, diarrhea, nausea, abdominal pain, vomiting, flatulence, dizziness, and joint pain. These side effects are usually temporary and may resolve over time. Persistent side effects should be reported to the doctor.
Safety Considerations:
PANBLEND is generally considered safe for pregnant and breastfeeding mothers, but it should be taken only after consulting a doctor. Inform your doctor about stomach or intestinal cancer, liver problems, allergies to PANTOPRAZOLE, or plans for future endoscopy.

Prolonged Use Considerations:
Long-term use of PANTOPRAZOLE may lead to deficiencies in Vitamin B12, as well as lower levels of calcium, magnesium, and Vitamin D, potentially contributing to osteoporosis.

Uses of PANTOPRAZOLE
Hyperacidity:
PANBLEND 40 is effective in reducing and controlling the excessive production of stomach acid, providing relief from symptoms associated with hyperacidity.
Heartburn:
PANBLEND 40 is used to alleviate heartburn, a burning sensation or discomfort in the chest caused by the reflux of stomach acid into the esophagus.
Peptic Ulcer:
PANBLEND 40 is utilized in the treatment of peptic ulcers, which are sores that develop on the inner lining of the stomach or the upper part of the small intestine. It helps in healing and preventing the recurrence of ulcers.
Directions for Use
Swallow it whole with water. Do not crush, break, or chew the tablet/capsule.
General Administration Note:
PANBLEND 40 should be given 30 minutes before meals.
Storage
Store in a cool and dry place away from sunlight

The post PANBLEND 40 appeared first on Jovaras.

Domperidone functions by enhancing the movement of food through the stomach and digestive tract, thereby reducing the sensation of bloating, fullness, and indigestion. Additionally, it effectively inhibits the action of the vomiting center (chemoreceptor trigger zone – CTZ) situated in the brain, responsible for triggering feelings of nausea and inducing vomiting. On the other hand, Pantoprazole contributes to the reduction of stomach acid by blocking the actions of an enzyme known as H+/K+ ATPase or gastric proton pump. This particular proton pump is located in the cells of the stomach wall and is responsible for releasing gastric acid, which can otherwise harm the tissues in the food pipe, stomach, and duodenum.4

PANTOPRAZOLE+DOMPERIDONE should be taken as prescribed by your doctor. As with all medications, it may cause side effects, although not everyone will experience them. The most commonly reported side effects of PANTOPRAZOLE+DOMPERIDONE include diarrhoea, stomach pain, flatulence (gas), dry mouth, dizziness, and headache. It’s important to note that not everyone will encounter these side effects. If you experience any discomfort or notice any unusual reactions, it is advisable to consult with your doctor for guidance. They can provide further assistance and may adjust your treatment plan if necessary.

It is advised not to use PANTOPRAZOLE+DOMPERIDONE if you are allergic to any of its ingredients. Prolonged use of Pantoprazole has been associated with a potential decrease in Vitamin B12 levels and magnesium. Therefore, it is recommended to undergo yearly tests for Vitamin B12 and magnesium if you are using PANTOPRAZOLE+DOMPERIDONE for an extended period. The use of PANTOPRAZOLE+DOMPERIDONE is contraindicated in individuals with lupus, an autoimmune inflammatory disease. Additionally, it is suggested to avoid the consumption of caffeine-containing beverages (such as coffee and tea), spicy/deep-fried/processed foods, carbonated drinks, and acidic foods like citrus fruits and vegetables (tomatoes). These dietary precautions can contribute to the overall effectiveness of the medication and help manage associated symptoms.

Uses of PANBLEND D
Gastroesophageal Reflux Disease (GERD): This medication is effective in managing GERD, a chronic condition where stomach acid flows back into the esophagus, causing irritation and discomfort.
Heartburn due to Hyperacidity: PANBLEND D helps alleviate heartburn, a symptom often associated with excessive stomach acid production.
Inflammation of the Food Pipe (Esophagitis): For cases of esophagitis, characterized by inflammation of the lining of the esophagus, this medication can provide relief from associated symptoms.
Peptic Ulcer: PANBLEND D is used in the treatment of peptic ulcers, which are open sores that develop on the inner lining of the stomach or the upper part of the small intestine.
Medicinal Benefits
PANBLEND D plays a crucial role in preventing various gastrointestinal conditions, including nausea, vomiting, stomach upset, stomach pain, peptic ulcers, and other issues related to hyperacidity or acid reflux. The combination of Pantoprazole and Domperidone contributes to its effectiveness. Pantoprazole functions by inhibiting the gate of proton pumps, reducing the excessive production of stomach acid. This action is vital in managing conditions associated with heightened acidity. On the other hand, Domperidone plays a key role in preventing nausea and vomiting by blocking communication between the chemoreceptor trigger zone (CTZ) and the vomiting center in the brain. This interruption in signals helps alleviate feelings of nausea and the act of vomiting. Together, these components in PANBLEND D provide comprehensive relief from various gastrointestinal symptoms and contribute to the overall management of acid-related conditions. It’s essential to use this medication as directed by your healthcare provider for optimal effectiveness. If you have any concerns or experience side effects, consult your doctor for guidance.
Directions for Use
The medication should be ingested whole with water; avoid crushing, breaking, or chewing it. This administration guideline ensures the proper release and effectiveness of the active ingredients in the medication. If you have any difficulty swallowing the medication, consult with your healthcare provider for alternative administration methods or formulations that may be more suitable for you.

CONTRAINDICATIONS
Pantoprazole: Hepatic impairment; hypersensitivity.
Domperidone: History of hypersensitivity to Dimenhydrinate or related compounds; GI Haemorrhage, Obstruction and Perforation, or after Surgery, Pregnancy.

The post PANBLEND D appeared first on Jovaras.

MYPG is a synergistic combination of two medications: Methylcobalamin/Mecobalamin (a form of vitamin B12) and Pregabalin (an anti-convulsant). Mecobalamin plays a crucial role in safeguarding nerve fibers and revitalizing nerve cells through the production of myelin. Meanwhile, Pregabalin functions by altering the way nerves transmit messages to the brain. Together, MECOBALAMIN+PREGABALIN effectively addresses neuropathic pain, which stems from nerve damage.

Adhere to the prescribed dosage of MYPG as directed by your doctor. The duration of MECOBALAMIN+PREGABALIN usage should align with your doctor’s recommendations based on your specific medical condition. Possible common side effects may include nausea, vomiting, stomach pain, diarrhea, loss of appetite, heartburn, dry mouth, dizziness, sleepiness, and uncoordinated body movements. Typically, these side effects are temporary and do not necessitate immediate medical attention. However, if any of these persist over time, it is advisable to consult with your doctor for further guidance.

Refrain from taking MECOBALAMIN+PREGABALIN if you are pregnant or breastfeeding, unless specifically prescribed by your doctor. Due to the potential for drowsiness and dizziness, it is advised to operate a vehicle only when fully alert while under the influence of MECOBALAMIN+PREGABALIN. This medication is not recommended for children, as its safety and effectiveness in this age group have not been established. Consumption of alcohol alongside MECOBALAMIN+PREGABALIN should be avoided to prevent heightened dizziness and sleepiness. Maintain open communication with your doctor regarding your health condition and other medications to ensure the identification of any potential side effects. Inform your doctor of any history of heart disease, severe kidney disease, disorders of the stomach or gut/bowel, or diabetes before initiating the use of MECOBALAMIN+PREGABALIN.

Uses of MECOBALAMIN+PREGABALIN
MECOBALAMIN+PREGABALIN is commonly prescribed to manage neuropathic pain associated with nerve damage or malfunctioning in conditions like diabetic peripheral neuropathy and postherpetic neuralgia. MECOBALAMIN, a form of vitamin B12, contributes to nerve health and function, while PREGABALIN, an anti-convulsant, alters nerve signals to alleviate pain. It’s essential to take this medication as directed by your doctor, and the duration of use will depend on your specific medical condition. If you have any concerns or questions about the uses of MECOBALAMIN+PREGABALIN, consult with your healthcare provider for personalized guidance.

Medicinal Benefits
The Medicinal Benefits of MECOBALAMIN+PREGABALIN are noteworthy. This combination of Mecobalamin and Pregabalin serves a dual purpose. Mecobalamin is instrumental in replenishing vitamin B12 levels, particularly crucial in addressing damaged nerve conditions arising from diabetes or other traumatic situations. Additionally, it exhibits neuroprotective properties, supporting proper nerve cell function and effectively treating neuropathic pain.
On the other hand, Pregabalin plays a pivotal role in preventing neuropathic pain linked to damaged nerves, as well as addressing musculoskeletal pain associated with fibromyalgia and controlling seizures in epilepsy. Its mechanism involves calming damaged or overactive nerves in the body, ultimately reducing the number of pain signals sent out by these compromised nerves. This comprehensive approach makes MECOBALAMIN+PREGABALIN a valuable solution for alleviating neuropathic pain arising from various conditions such as chronic illnesses, diabetes, trauma, or epilepsy.

Directions for Use
Swallow it as a whole Tablet with water; do not crush, break or chew it.
Storage
Store in a cool and dry place away from sunlight
Side Effects of MECOBALAMIN+PREGABALIN
• Drowsiness: Feeling excessively sleepy or lethargic.
• Dizziness: Experiencing a spinning sensation or feeling lightheaded.
• Dry mouth: A sensation of dryness in the mouth.
• Nausea: Feeling the urge to vomit.
• Vomiting: The act of forcefully expelling stomach contents through the mouth.
• Stomach pain: Discomfort or pain in the abdominal area.
• Diarrhea: Increased frequency of bowel movements with loose or watery stools.
• Loss of appetite: Decreased desire to eat or a lack of interest in food.
• Heartburn: A burning sensation or discomfort in the chest, often caused by stomach acid.
• Uncoordinated body movements: Difficulty in controlling or coordinating bodily movements.

The post MYPG appeared first on Jovaras.